A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts

Multinuclear platinum compounds were rationally designed to bind to DNA in a different manner from that of cisplatin and its mononuclear analogues. A triplatinum compound of the series (BBR 3464) was selected for preclinical development, since, in spite of its charged nature, it was very potent as c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pratesi, G, Perego, P, Polizzi, D, Righetti, S C, Supino, R, Caserini, C, Manzotti, C, Giuliani, F C, Pezzoni, G, Tognella, S, Spinelli, S, Farrell, N, Zunino, F
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1999
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363141/
https://ncbi.nlm.nih.gov/pubmed/10471039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690620
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados